Celerion, a provider of early stage drug development solutions, has been awarded LEED Silver established by the U.S. Green Building Council and verified by the Green Building Certification Institute (GBCI). LEED is the nation’s program for the design, construction and operation of high performance green buildings.

Celerion’s facility in Phoenix, Arizona is a 300 bed, early clinical research facility and is the Center of Excellence for early cardiac studies. Celerion was the first CRO to launch the hybrid phase I/ECG core lab, which was developed in Phoenix, and launched to Celerion’s global network of clinics.

Celerion achieved certification under the for its  energy use, lighting, water and material use, as well as incorporating a variety of other sustainable strategies to make it the first research clinic of its type in the country to attain such an honor. By using less energy and water, LEED certified buildings save money for families, businesses and taxpayers; reduce greenhouse gas emissions; and contribute to a healthier environment for residents, workers and the larger community.